| Literature DB >> 34873435 |
Weijun Gao1, Peibo Zhang2, Hui Wang1, Pengfei Tuo3, Zhiqing Li3.
Abstract
This work aimed to explore the accuracy of magnetic resonance imaging (MRI) images based on the convolutional neural network (CNN) algorithm in the diagnosis of prostate cancer patients and tumor risk grading. A total of 89 patients with prostate cancer and benign prostatic hyperplasia diagnosed by MRI examination and pathological examination in hospital were selected as the research objects in this study (they passed the exclusion criteria). The MRI images of these patients were collected in two groups and divided into two groups before and after treatment according to whether the CNN algorithm was used to process them. The number of diagnosed diseases and the number of cases of risk level inferred based on the tumor grading were compared to observe which group was closer to the diagnosis of pathological biopsy. Through comparative analysis, compared with the positive rate of pathological diagnosis (44%), the positive rate after the treatment of the CNN algorithm (42%) was more similar to that before the treatment (34%), and the comparison was statistically marked (P < 0.05). In terms of risk stratification, the grading results after treatment (37 cases) were closer to the results of pathological grading (39 cases) than those before treatment (30 cases), and the comparison was statistically obvious (P < 0.05). In addition, it was obvious that the MRT images would be clearer after treatment through the observation of the MRT images before and after treatment. In conclusion, MRI image segmentation algorithm based on CNN was more accurate in the diagnosis and risk stratification of prostate cancer than routine MRI. According to the evaluation of Dice similarity coefficient (DSC) and Hausdorff I distance (HD), the CNN segmentation method used in this study was more perfect than other segmentation methods.Entities:
Mesh:
Year: 2021 PMID: 34873435 PMCID: PMC8643240 DOI: 10.1155/2021/1034661
Source DB: PubMed Journal: J Healthc Eng ISSN: 2040-2295 Impact factor: 2.682
Figure 1MRI scanning process.
Figure 2Process of segmentation of prostate based on CNN algorithm.
Gleason grading criteria.
| Grading | Manifestation |
|---|---|
| Gleason1 | Cancer tissue is extremely rare. Its borders are very clear, it grows expansively, and it hardly invades the matrix; the carcinomas are simple, usually round, and moderately sized and are packed together; the cytoplasm of cancer cells closely resembles that of benign epithelial cells. |
| Gleason2 | Cancer tissue is rare, which mostly occurs in the transitional area of the prostate. The tumor boundary is not very clear, and the carcinomas are separated by the stroma. They are simple, round, different in size, and irregular in shape and are loosely arranged together. |
| Gleason3 | Cancer tissue is the most common, which mostly occurs in the peripheral area of the prostate. Its most important feature is invasive growth, the carcinomas are of different sizes and shapes, nucleoli are large and red, and the cytoplasm is mostly alkaline staining. |
| Gleason4 | The cancer tissue is poorly differentiated and grows infiltrating; the carcinomas are irregularly fused to form tiny papillary or sieve-shaped, large and red nucleoli; the cytoplasm can be alkaline or gray. |
| Gleason5 | The cancer tissue is very poorly differentiated. The border can be regularly round or irregular, accompanied by invasive growth; the growth form is sheet-like single cell type or acne-like carcinoma type, accompanied by necrosis; cancer cells have large nuclei and large and red nucleoli; cytoplasmic staining may vary. |
Figure 3Comparison on DSC and HD results of different MRI segmentation methods.
Figure 4MRI images of normal prostate: (a) the coronal section and (b) the horizontal section.
Figure 5Comparison on MRI images of prostate cancer and benign prostatic hyperplasia. (a) Prostate cancer. (b) Hyperplasia of prostate.
Figure 6Comparison on MRI images of prostate cancer and prostate hyperplasia after optimized treatment. (a) Prostate cancer. (b) Hyperplasia of prostate.
The detection results of prostate through pathological biopsy and MRI.
| Detection methods | Symptoms | ||
|---|---|---|---|
| Cancer | Hyperplasia | ||
| Results of histopathological examination | 39 | 50 | |
| Results of histopathological MRI examination | Before processing | 30 | 59 |
| After processing | 37 | 52 | |
Figure 7Comparison on the MRI results before and after image processing and the results of pathological biopsy: (a) before processing; (b) after processing.
Results of prostate cancer risk stratification under different test methods.
| Low-risk group | Medium-risk group | High-risk group | ||
|---|---|---|---|---|
| Pathological examination | 14 | 17 | 8 | |
| MRI | Before processing | 20 | 9 | 10 |
| After processing | 15 | 16 | 8 | |
Tthe difference was statistically marked (P < 0.05).
Figure 8Comparison on risk levels of MRI before image processing and pathological examination.
Figure 9Comparison on the risk levels between MRI after image processing and pathological examination.